Category: News

Resumen: NovaTears® estabiliza de forma significativa la película lagrimal y alivia los síntomas del síndrome del ojo seco en pacientes con la enfermedad del ojo seco evaporativo

HEIDELBERG, Alemania–(BUSINESS WIRE)–Un nuevo estudio ha demsotrado que NovaTears®, el primer colirio tópico disponible a la venta de Novaliq GmbH para el tratamiento de la enfermedad del ojo seco evaporativo, ha mejorado de manera significativa cuatro o cinco medidas asociadas con la enfermedad. El comunicado en el idioma original, es la versión oficial y autorizada del mismo. La traducción es solamente un medio de ayuda y deberá ser comparada con el texto en idioma original, que es la única


$4 Million Contributed to Establish Chair for The Vision Center at Children’s Hospital Los Angeles

LOS ANGELES–(BUSINESS WIRE)–Two philanthropic gifts, totaling $4 million, have been pledged in support of The Vision Center at Children’s Hospital Los Angeles, an international referral center for children with complex eye diseases. A $2 million gift from the Larry & Celia Moh Foundation to The Vision Center will help establish the A. Linn Murphree Retinoblastoma Program Chair. CHLA ophthalmologist A. Linn Murphree, MD, established the retinoblastoma center at Children’s Hospital Los Ange


Clinical Data from ReVision Optics’ Raindrop Near Vision Inlay Featured in Two Presentations at the OIS@AAO Conference

LAKE FOREST, Calif.–(BUSINESS WIRE)–ReVision Optics, Inc., a leader in implantable presbyopia-correcting corneal inlay technology, announces that clinical data from its Raindrop® Near Vision Inlay for the treatment of presbyopia was the subject of two presentations at the 2015 OIS@AAO conference, held last month in Las Vegas. At the conference, John Kilcoyne, ReVision Optics President and Chief Executive Officer, presented an overview of clinical data from 344 patients followed for 24 months


Clinical Data from ReVision Optics’ Raindrop Near Vision Inlay Featured in Two Presentations at the OIS@AAO Conference

LAKE FOREST, Calif.–(BUSINESS WIRE)–ReVision Optics, Inc., a leader in implantable presbyopia-correcting corneal inlay technology, announces that clinical data from its Raindrop® Near Vision Inlay for the treatment of presbyopia was the subject of two presentations at the 2015 OIS@AAO conference, held last month in Las Vegas. At the conference, John Kilcoyne, ReVision Optics President and Chief Executive Officer, presented an overview of clinical data from 344 patients followed for 24 months


Eye Implant for Producing Tears to Fight Dry Eye Syndrome

Dry eye syndrome may soon be treated with a new implant developed by a team led by researchers at Stanford University. The team identified the afferent neural pathway as being an excellent target for stimulation in order to activate tear production. They built a device that has platinum foil electrodes implanted under the inferior lacrimal [&hellip (Read more...)